Foster & Motley’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.5M | Sell |
28,566
-1,165
| -4% | -$586K | 0.7% | 29 |
|
|
2025
Q4 | $13.9M | Sell |
29,731
-2,925
| -9% | -$1.36M | 0.74% | 28 |
|
|
2025
Q3 | $13.9M | Sell |
32,656
-849
| -3% | -$329K | 0.75% | 27 |
|
|
2025
Q2 | $12.8M | Sell |
33,505
-422
| -1% | -$152K | 0.74% | 29 |
|
|
2025
Q1 | $11.7M | Sell |
33,927
-579
| -2% | -$186K | 0.74% | 28 |
|
|
2024
Q4 | $10.4M | Buy |
34,506
+293
| +0.9% | +$102K | 0.67% | 31 |
|
|
2024
Q3 | $13.9M | Sell |
34,213
-143
| -0.4% | -$52.4K | 0.88% | 20 |
|
|
2024
Q2 | $11M | Sell |
34,356
-108
| -0.3% | -$35.1K | 0.76% | 27 |
|
|
2024
Q1 | $11.5M | Buy |
34,464
+403
| +1% | +$123K | 0.79% | 24 |
|
|
2023
Q4 | $9.22M | Buy |
34,061
+1,300
| +4% | +$321K | 0.69% | 34 |
|
|
2023
Q3 | $8.06M | Buy |
32,761
+186
| +0.6% | +$50.9K | 0.66% | 33 |
|
|
2023
Q2 | $9.89M | Buy |
32,575
+404
| +1% | +$112K | 0.77% | 23 |
|
|
2023
Q1 | $8.48M | Buy |
32,171
+3,067
| +11% | +$779K | 0.69% | 28 |
|
|
2022
Q4 | $6.98M | Buy |
29,104
+765
| +3% | +$171K | 0.6% | 35 |
|
|
2022
Q3 | $5.21M | Buy |
28,339
+417
| +1% | +$83.1K | 0.49% | 49 |
|
|
2022
Q2 | $4.69M | Buy |
27,922
+2,027
| +8% | +$435K | 0.41% | 56 |
|
|
2022
Q1 | $6.49M | Sell |
25,895
-732
| -3% | -$184K | 0.51% | 43 |
|
|
2021
Q4 | $6.84M | Sell |
26,627
-1,073
| -4% | -$263K | 0.53% | 50 |
|
|
2021
Q3 | $6.72M | Buy |
27,700
+635
| +2% | +$155K | 0.56% | 48 |
|
|
2021
Q2 | $5.59M | Sell |
27,065
-516
| -2% | -$105K | 0.47% | 57 |
|
|
2021
Q1 | $5.2M | Sell |
27,581
-567
| -2% | -$100K | 0.43% | 61 |
|
|
2020
Q4 | $4.63M | Buy |
28,148
+143
| +0.5% | +$20.9K | 0.45% | 62 |
|
|
2020
Q3 | $3.49M | Sell |
28,005
-213
| -0.8% | -$26.4K | 0.41% | 68 |
|
|
2020
Q2 | $2.74M | Sell |
28,218
-2,868
| -9% | -$298K | 0.34% | 86 |
|
|
2020
Q1 | $2.79M | Buy |
31,086
+2,669
| +9% | +$346K | 0.42% | 69 |
|
|
2019
Q4 | $4.2M | Buy |
28,417
+1,552
| +6% | +$208K | 0.53% | 51 |
|
|
2019
Q3 | $3.23M | Buy |
26,865
+2,459
| +10% | +$318K | 0.44% | 62 |
|
|
2019
Q2 | $3.3M | Buy |
24,406
+4,704
| +24% | +$595K | 0.46% | 62 |
|
|
2019
Q1 | $2.57M | Buy |
19,702
+8,628
| +78% | +$1.16M | 0.37% | 80 |
|
|
2018
Q4 | $1.38M | Buy |
11,074
+5,927
| +115% | +$796K | 0.22% | 108 |
|
|
2018
Q3 | $716K | Buy |
5,147
+1,730
| +51% | +$215K | 0.11% | 148 |
|
|
2018
Q2 | $351K | Buy |
+3,417
| New | +$346K | 0.06% | 187 |
|
Other funds holding HCA
VCM
VPM
Foster & Motley's HCA Position: Q1 2026 in Review
Foster & Motley reduced its HCA Healthcare (HCA) stake by 3.9% in Q1 2026, selling an estimated $586K and leaving 28,566 shares worth $13.5M. The position accounts for 0.7% of the portfolio, ranked #29.
Foster & Motley first reported a position in HCA in Q2 2018 and has held it in 32 quarters since. The position peaked at $13.9M in Q3 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Foster & Motley held 28,566 shares of HCA Healthcare worth $13.5M as of Q1 2026.
- Foster & Motley sold 1,165 HCA Healthcare shares in Q1 2026, an estimated $586K.
- HCA Healthcare made up 0.7% of Foster & Motley's portfolio in Q1 2026, its #29 holding.
- Foster & Motley first reported a position in HCA Healthcare in Q2 2018 and has held it in 32 quarters since.
- Foster & Motley's HCA Healthcare position peaked at $13.9M in Q3 2025.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.